Lack of TERT Promoter Mutations in Human B-Cell Non-Hodgkin Lymphoma
Open Access
Abstract
Non-Hodgkin lymphomas (NHL) are a heterogeneous group of immune cell neoplasms that comprise molecularly distinct lymphoma subtypes. Recent work has identified high frequency promoter point mutations in the telomerase reverse transcriptase (TERT) gene of different cancer types, including melanoma, glioma, liver and bladder cancer. TERT promoter mutations appear to correlate with increased TERT expression and telomerase activity in these cancers. In contrast, breast, pancreatic, and prostate cancer rarely demonstrate mutations in this region of the gene. TERT promoter mutation prevalence in NHL has not been thoroughly tested thus far. We screened 105 B-cell lymphoid malignancies encompassing nine NHL subtypes and acute lymphoblastic leukemia, for TERT promoter mutations. Our results suggest that TERT promoter mutations are rare or absent in most NHL. Thus, the classical TERT promoter mutations may not play a major oncogenic role in TERT expression and telomerase activation in NHL.Keywords
Funding Information
- National Institutes of Health (RO1 CA124596, T32GM007231)
This publication has 30 references indexed in Scilit:
- Highly Recurrent TERT Promoter Mutations in Human MelanomaScience, 2013
- Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencingProceedings of the National Academy of Sciences, 2012
- Telomeres and telomerase in normal and malignant B‐cellsHematological Oncology, 2010
- Impact of TET2 mutations on mRNA expression and clinical outcomes in MDS patients treated with DNA methyltransferase inhibitorsHematological Oncology, 2010
- Telomerase reverse transcriptase expression elevated by avian leukosis virus integration in B cell lymphomasProceedings of the National Academy of Sciences, 2007
- Telomeres and telomerase in leukaemia and lymphomaTransfusion and Apheresis Science, 2007
- Update on the molecular biology of mantle cell lymphomaHematological Oncology, 2006
- TERT regulates cell survival independent of telomerase enzymatic activityOncogene, 2002
- Telomeres and telomerase in hematologic neoplasiaOncogene, 2002
- Prognostic Significance of Bone Marrow Trephine and Peripheral Blood Smears in 55 Patients with Mantle Cell LymphomaLeukemia & Lymphoma, 1996